Oncotarget

Vol 9, No 61

August 7, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 61 of Oncotarget features Figure 3, "The effect of loss of CD38 on blood vessels, necrotic area, peritumoral area and amount of CAFs in late stage tumors effect on blood vessels density," by Baruch, et al.

Table of Contents

News

Stem cells: a window of opportunity in low-dimensional EMT space

Stem cells: a window of opportunity in low-dimensional EMT space

https://doi.org/10.18632/oncotarget.25852

Qing Nie
31790-31791
PDF  |  Order a Reprint

A potential novel option for cancer immunotherapy – TLR7 stimulation inhibits malignant melanoma bone invasion

A potential novel option for cancer immunotherapy – TLR7 stimulation inhibits malignant melanoma bone invasion

https://doi.org/10.18632/oncotarget.25872

Takenobu Katagiri
31792-31792
PDF  |  Order a Reprint

A new twist to V-ATPases and cancer

A new twist to V-ATPases and cancer

https://doi.org/10.18632/oncotarget.25883

Michael Forgac
31793-31794
PDF  |  Order a Reprint

Editorial

Implementation of cancer treatment during pregnancy in daily practice: the important role of perinatologists

Implementation of cancer treatment during pregnancy in daily practice: the important role of perinatologists

https://doi.org/10.18632/oncotarget.25841

Koen F. de Geus, Charlotte Maggen, Jorine de Haan,  and Frédéric Amant
31795-31796
PDF  |  Order a Reprint

Priority Research Papers

Stromal CD38 regulates outgrowth of primary melanoma and generation of spontaneous metastasis

Stromal CD38 regulates outgrowth of primary melanoma and generation of spontaneous metastasis

https://doi.org/10.18632/oncotarget.25737

Bar Ben Baruch, Eran Blacher, Einav Mantsur, Hila Schwartz, Hananya Vaknine, Neta Erez,  and Reuven Stein
31797-31811
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Research Papers

Immunologically effective dose: a practical model for immunoradiotherapy

Immunologically effective dose: a practical model for immunoradiotherapy

https://doi.org/10.18632/oncotarget.25746

Raphaël Serre, Fabrice Barlesi, Xavier Muracciole,  and Dominique Barbolosi
31812-31819
Abstract  |  PDF  |  HTML  |  Order a Reprint

Development of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX

Development of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX

https://doi.org/10.18632/oncotarget.25806

Theodore Vougiouklakis, Vassiliki Saloura, Jae-Hyun Park, Naofumi Takamatsu, Takashi Miyamoto, Yusuke Nakamura,  and Yo Matsuo
31820-31831
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

LEE011 and ruxolitinib: a synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)

LEE011 and ruxolitinib: a synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)

https://doi.org/10.18632/oncotarget.25835

Yan Ting Hee, Junli Yan, Dean Nizetic,  and Wee-Joo Chng
31832-31841
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors

c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors

https://doi.org/10.18632/oncotarget.25867

Katia Corano Scheri, Erica Leonetti, Luigi Laino, Vincenzo Gigantino, Luisa Gesualdi, Paola Grammatico, Mariano Bizzari, Renato Franco, J. Wolter Oosterhuis, Hans Stoop, Leendert H.J. Looijenga, Giulia Ricci,  and Angela Catizone
31842-31860
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study

Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study

https://doi.org/10.18632/oncotarget.25870

Gemma Bruera, Silvia Massacese, Stefania Candria, Antonio Galvano, Rosa Manetta, Aldo Victor Giordano, Sergio Carducci, Alessandra Di Sibio, Eugenio Ciacco, Antonio Russo, Enrico Ricevuto,  and on behalf of Oncology Network ASL1 Abruz, Italy
31861-31876
Abstract  |  PDF  |  HTML  |  Order a Reprint

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

https://doi.org/10.18632/oncotarget.25874

Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, Alberto Fumagalli, Donata Sartori, Maria Rosaria Valerio, Mario Airoldi, Gabriella Moretti, Corrado Ficorella, Valentina Arcangeli, Lucrezia Diodati, Alberto Zambelli, Antonio Febbraro, Daniele Generali, Mirco Pistelli, Ornella Garrone, Antonino Musolino, Patrizia Vici, Michela Maur, Lucia Mentuccia, Nicla La Verde, Giulia Bianchi, Salvatore Artale, Livio Blasi, Matilde Piezzo, Francesco Atzori, Anna Turletti, Chiara Benedetto, Maria Concetta Cursano, Alessandra Fabi, Vittorio Gebbia, Alessio Schirone, Raffaella Palumbo, Antonella Ferzi, Antonio Frassoldati, Claudio Scavelli, Luca Clivio,  and Valter Torri on behalf of The EVA Study Group
31877-31887
Abstract  |  PDF  |  HTML  |  Order a Reprint

Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma

Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma

https://doi.org/10.18632/oncotarget.25879

Mohammad Krayem, Ahmad Najem, Fabrice Journe, Renato Morandini, François Sales, Ahmad Awada,  and Ghanem E. Ghanem
31888-31903
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy

Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy

https://doi.org/10.18632/oncotarget.25881

Akemi Sato, Chiho Nakashima, Tomonori Abe, Junichi Kato, Mitsuharu Hirai, Tomomi Nakamura, Kazutoshi Komiya, Shinya Kimura, Eisaburo Sueoka,  and Naoko Sueoka-Aragane
31904-31914
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Reviews

Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results

Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results

https://doi.org/10.18632/oncotarget.25739

Alberto Ocaña, Eitan Amir,  and Atanasio Pandiella
31915-31919
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Virus and tumor microenvironment induced ER stress and unfolded protein response: from complexity to therapeutics

Virus and tumor microenvironment induced ER stress and unfolded protein response: from complexity to therapeutics

https://doi.org/10.18632/oncotarget.25886

Kumari Asha,  and Neelam Sharma-Walia
31920-31936
Abstract  |  PDF  |  HTML  |  Order a Reprint

Corrections

Correction: Consumption of fruits and vegetables and risk of renal cell carcinoma: a meta-analysis of observational studies

Correction: Consumption of fruits and vegetables and risk of renal cell carcinoma: a meta-analysis of observational studies

https://doi.org/10.18632/oncotarget.25969

Shaojin Zhang, Zhankui Jia, Zechen Yan,  and Jinjian Yang
31937-31937
Correction  |  PDF

Correction: A genetic variant in SLC28A3, rs56350726, is associated with progression to castration-resistant prostate cancer in a Korean population with metastatic prostate cancer

Correction: A genetic variant in SLC28A3, rs56350726, is associated with progression to castration-resistant prostate cancer in a Korean population with metastatic prostate cancer

https://doi.org/10.18632/oncotarget.25970

Jung Ki Jo, Jong Jin Oh, Yong Tae Kim, Hong Sang Moon, Hong Yong Choi, Seunghyun Park, Jin-Nyoung Ho, Sungroh Yoon, Hae Young Park,  and Seok-Soo Byun
31938-31938
Correction  |  PDF


Copyright © 2018 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC